In this video, Stephanie Nahas, MD, MSEd, reviews take-home messages for headache specialists on the use of telemedicine.
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, reviews major intravenous thrombolysis trial data that emerged in 2020, including data for extending thrombolysis beyond the traditional 4.5-hour window, data from the EXTEND-IA TNK Part 2 Randomized Clinical Trial, and more. A full transcript is provided.
In Episode 1, Rachel Marie E. Salas, MD, interviews Nancy Collop, MD, and Charlene Gamaldo, MD, about the impact of COVID-19 on their sleep centers at Emory University and Johns Hopkins University, respectively, from the start of the pandemic until now. A full transcript is provided.
In this podcast, Joohi Jimenez-Shahed, MD, discusses the findings of the study, “Safety, Tolerability, and Pharmacodynamic Profile of DNL201 at dose levels demonstrating LRRK2 inhibition in Parkinson's Disease Patients with and without LRRK2 mutations,” which was presented at the International Parkinson and Movement Disorder Society Virtual Congress.
Neurology Learning Network spoke with Sami Khella, MD, who gave a talk on new and emerging therapies for amyloidosis at the American Neurological Association’s 145th Annual Meeting.
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, gives a snapshot of key stroke prevention trial data that were unveiled in 2020—the THALES trial, the RIVER trial, and the Treat Stroke to Target Trial. A full transcript is provided.
In this podcast, Neurology Learning Network's Sleep Medicine Section Editor Joseph Diamond, MD, discusses new drug approvals, phase 3 clinical trial data, "COVID-somnia," and more developments from 2020. A full transcript is provided.
In this video, Neurology Learning Network’s Migraine Section Editor Stephanie Nahas, MD, reviews key developments in the field of headache and migraine this year, including new therapeutics, virtual conferences, and more. A full transcript is provided.
In a recent systematic review, investigators examined the effects of medical marijuana on neurological symptoms among patients with Huntington disease. Senior study author Rana Zeine, MD, PhD, MBA, answered our questions about the findings in this review and their clinical implications.
In this podcast, Dr Coyle discusses the "final word" on strategies to promote remyelination in multiple sclerosis from the ECTRIMS/ACTRIMS MSVirtual2020 meeting.